Status:
RECRUITING
Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research
Lead Sponsor:
Second Xiangya Hospital of Central South University
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
Brief Summary
The China Alliance for Type 1 Diabetes (CAT1D) is committed to exploring and implementing the model of graded diagnosis and treatment of type 1 diabetes and comprehensive management of outpatient serv...
Detailed Description
1. Through the CAT1D, expand the cohort construction of type 1 diabetes patients and first-level relatives in China, establish the electronic information database of type 1 diabetes, and lay a foundat...
Eligibility Criteria
Inclusion
- Individuals diagnosed with Type 1 Diabetes according to the 1999 World Health Organization report
- Written informed consent from the patient or family representative;
- Individuals who own smartphone and are capable of using wechat or apps
Exclusion
- Non-t1dm patients with autoimmune polyendocrine adenopathy syndrome (APS) are the first disease
- With mental disorders
- Have any other condition or disease that may hamper from compliance with the protocol or complication of the trial
Key Trial Info
Start Date :
September 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04096794
Start Date
September 1 2016
End Date
September 1 2027
Last Update
April 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Changsha, Hunan, China, 410011